The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Coagulation Factors-Global Market Insights and Sales Trends 2024
Synopsis
Coagulation factors such as factor V, factor VIII and factor X play a role in blood clotting
The global Coagulation Factors market size is expected to reach US$ 18800 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Coagulation Factors in various end use industries. The expanding demands from the Pharmacy and Hospital, are propelling Coagulation Factors market. Plasma-derived, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant segment is estimated at % CAGR for the next seven-year period.
The coagulation factors market has experienced substantial growth in recent years. Coagulation factors are essential proteins involved in the blood clotting process, and deficiencies or abnormalities in these factors can lead to bleeding disorders such as hemophilia and von Willebrand disease. The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Coagulation Factors, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Coagulation Factors market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Coagulation Factors market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Coagulation Factors sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Coagulation Factors covered in this report include Takeda, Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk and Greencross, etc.
The global Coagulation Factors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Global Coagulation Factors market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Coagulation Factors market, Segment by Type:
Plasma-derived
Recombinant
Global Coagulation Factors market, by Application
Pharmacy
Hospital
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Coagulation Factors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Coagulation Factors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Coagulation factors such as factor V, factor VIII and factor X play a role in blood clotting
The global Coagulation Factors market size is expected to reach US$ 18800 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Coagulation Factors in various end use industries. The expanding demands from the Pharmacy and Hospital, are propelling Coagulation Factors market. Plasma-derived, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant segment is estimated at % CAGR for the next seven-year period.
The coagulation factors market has experienced substantial growth in recent years. Coagulation factors are essential proteins involved in the blood clotting process, and deficiencies or abnormalities in these factors can lead to bleeding disorders such as hemophilia and von Willebrand disease. The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Coagulation Factors, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Coagulation Factors market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Coagulation Factors market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Coagulation Factors sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Coagulation Factors covered in this report include Takeda, Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk and Greencross, etc.
The global Coagulation Factors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Global Coagulation Factors market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Coagulation Factors market, Segment by Type:
Plasma-derived
Recombinant
Global Coagulation Factors market, by Application
Pharmacy
Hospital
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Coagulation Factors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Coagulation Factors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Coagulation Factors Market Overview
1.1 Coagulation Factors Product Overview
1.2 Coagulation Factors Market Segment by Type
1.2.1 Plasma-derived
1.2.2 Recombinant
1.3 Global Coagulation Factors Market Size by Type
1.3.1 Global Coagulation Factors Market Size Overview by Type (2018-2029)
1.3.2 Global Coagulation Factors Historic Market Size Review by Type (2018-2023)
1.3.3 Global Coagulation Factors Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Coagulation Factors Sales Breakdown by Type (2018-2023)
1.4.2 Europe Coagulation Factors Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Coagulation Factors Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Coagulation Factors Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Coagulation Factors Sales Breakdown by Type (2018-2023)
2 Global Coagulation Factors Market Competition by Company
2.1 Global Top Players by Coagulation Factors Sales (2018-2023)
2.2 Global Top Players by Coagulation Factors Revenue (2018-2023)
2.3 Global Top Players by Coagulation Factors Price (2018-2023)
2.4 Global Top Manufacturers Coagulation Factors Manufacturing Base Distribution, Sales Area, Product Type
2.5 Coagulation Factors Market Competitive Situation and Trends
2.5.1 Coagulation Factors Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Coagulation Factors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Coagulation Factors as of 2022)
2.7 Date of Key Manufacturers Enter into Coagulation Factors Market
2.8 Key Manufacturers Coagulation Factors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Coagulation Factors Status and Outlook by Region
3.1 Global Coagulation Factors Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Coagulation Factors Historic Market Size by Region
3.2.1 Global Coagulation Factors Sales in Volume by Region (2018-2023)
3.2.2 Global Coagulation Factors Sales in Value by Region (2018-2023)
3.2.3 Global Coagulation Factors Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Coagulation Factors Forecasted Market Size by Region
3.3.1 Global Coagulation Factors Sales in Volume by Region (2024-2029)
3.3.2 Global Coagulation Factors Sales in Value by Region (2024-2029)
3.3.3 Global Coagulation Factors Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Coagulation Factors by Application
4.1 Coagulation Factors Market Segment by Application
4.1.1 Pharmacy
4.1.2 Hospital
4.2 Global Coagulation Factors Market Size by Application
4.2.1 Global Coagulation Factors Market Size Overview by Application (2018-2029)
4.2.2 Global Coagulation Factors Historic Market Size Review by Application (2018-2023)
4.2.3 Global Coagulation Factors Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Coagulation Factors Sales Breakdown by Application (2018-2023)
4.3.2 Europe Coagulation Factors Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Coagulation Factors Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Coagulation Factors Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Coagulation Factors Sales Breakdown by Application (2018-2023)
5 North America Coagulation Factors by Country
5.1 North America Coagulation Factors Historic Market Size by Country
5.1.1 North America Coagulation Factors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Coagulation Factors Sales in Volume by Country (2018-2023)
5.1.3 North America Coagulation Factors Sales in Value by Country (2018-2023)
5.2 North America Coagulation Factors Forecasted Market Size by Country
5.2.1 North America Coagulation Factors Sales in Volume by Country (2024-2029)
5.2.2 North America Coagulation Factors Sales in Value by Country (2024-2029)
6 Europe Coagulation Factors by Country
6.1 Europe Coagulation Factors Historic Market Size by Country
6.1.1 Europe Coagulation Factors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Coagulation Factors Sales in Volume by Country (2018-2023)
6.1.3 Europe Coagulation Factors Sales in Value by Country (2018-2023)
6.2 Europe Coagulation Factors Forecasted Market Size by Country
6.2.1 Europe Coagulation Factors Sales in Volume by Country (2024-2029)
6.2.2 Europe Coagulation Factors Sales in Value by Country (2024-2029)
7 Asia-Pacific Coagulation Factors by Region
7.1 Asia-Pacific Coagulation Factors Historic Market Size by Region
7.1.1 Asia-Pacific Coagulation Factors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Coagulation Factors Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Coagulation Factors Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Coagulation Factors Forecasted Market Size by Region
7.2.1 Asia-Pacific Coagulation Factors Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Coagulation Factors Sales in Value by Region (2024-2029)
8 Latin America Coagulation Factors by Country
8.1 Latin America Coagulation Factors Historic Market Size by Country
8.1.1 Latin America Coagulation Factors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Coagulation Factors Sales in Volume by Country (2018-2023)
8.1.3 Latin America Coagulation Factors Sales in Value by Country (2018-2023)
8.2 Latin America Coagulation Factors Forecasted Market Size by Country
8.2.1 Latin America Coagulation Factors Sales in Volume by Country (2024-2029)
8.2.2 Latin America Coagulation Factors Sales in Value by Country (2024-2029)
9 Middle East and Africa Coagulation Factors by Country
9.1 Middle East and Africa Coagulation Factors Historic Market Size by Country
9.1.1 Middle East and Africa Coagulation Factors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Coagulation Factors Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Coagulation Factors Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Coagulation Factors Forecasted Market Size by Country
9.2.1 Middle East and Africa Coagulation Factors Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Coagulation Factors Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Takeda
10.1.1 Takeda Company Information
10.1.2 Takeda Introduction and Business Overview
10.1.3 Takeda Coagulation Factors Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Takeda Coagulation Factors Products Offered
10.1.5 Takeda Recent Development
10.2 Bayer
10.2.1 Bayer Company Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Coagulation Factors Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bayer Coagulation Factors Products Offered
10.2.5 Bayer Recent Development
10.3 CSL
10.3.1 CSL Company Information
10.3.2 CSL Introduction and Business Overview
10.3.3 CSL Coagulation Factors Sales, Revenue and Gross Margin (2018-2023)
10.3.4 CSL Coagulation Factors Products Offered
10.3.5 CSL Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Coagulation Factors Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Coagulation Factors Products Offered
10.4.5 Pfizer Recent Development
10.5 Grifols
10.5.1 Grifols Company Information
10.5.2 Grifols Introduction and Business Overview
10.5.3 Grifols Coagulation Factors Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Grifols Coagulation Factors Products Offered
10.5.5 Grifols Recent Development
10.6 Biogen
10.6.1 Biogen Company Information
10.6.2 Biogen Introduction and Business Overview
10.6.3 Biogen Coagulation Factors Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Biogen Coagulation Factors Products Offered
10.6.5 Biogen Recent Development
10.7 Octapharma
10.7.1 Octapharma Company Information
10.7.2 Octapharma Introduction and Business Overview
10.7.3 Octapharma Coagulation Factors Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Octapharma Coagulation Factors Products Offered
10.7.5 Octapharma Recent Development
10.8 NovoNordisk
10.8.1 NovoNordisk Company Information
10.8.2 NovoNordisk Introduction and Business Overview
10.8.3 NovoNordisk Coagulation Factors Sales, Revenue and Gross Margin (2018-2023)
10.8.4 NovoNordisk Coagulation Factors Products Offered
10.8.5 NovoNordisk Recent Development
10.9 Greencross
10.9.1 Greencross Company Information
10.9.2 Greencross Introduction and Business Overview
10.9.3 Greencross Coagulation Factors Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Greencross Coagulation Factors Products Offered
10.9.5 Greencross Recent Development
10.10 Kedrion
10.10.1 Kedrion Company Information
10.10.2 Kedrion Introduction and Business Overview
10.10.3 Kedrion Coagulation Factors Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Kedrion Coagulation Factors Products Offered
10.10.5 Kedrion Recent Development
10.11 BPL
10.11.1 BPL Company Information
10.11.2 BPL Introduction and Business Overview
10.11.3 BPL Coagulation Factors Sales, Revenue and Gross Margin (2018-2023)
10.11.4 BPL Coagulation Factors Products Offered
10.11.5 BPL Recent Development
10.12 Hualan Bio
10.12.1 Hualan Bio Company Information
10.12.2 Hualan Bio Introduction and Business Overview
10.12.3 Hualan Bio Coagulation Factors Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Hualan Bio Coagulation Factors Products Offered
10.12.5 Hualan Bio Recent Development
10.13 RAAS
10.13.1 RAAS Company Information
10.13.2 RAAS Introduction and Business Overview
10.13.3 RAAS Coagulation Factors Sales, Revenue and Gross Margin (2018-2023)
10.13.4 RAAS Coagulation Factors Products Offered
10.13.5 RAAS Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Coagulation Factors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Coagulation Factors Industrial Chain Analysis
11.4 Coagulation Factors Market Dynamics
11.4.1 Coagulation Factors Industry Trends
11.4.2 Coagulation Factors Market Drivers
11.4.3 Coagulation Factors Market Challenges
11.4.4 Coagulation Factors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Coagulation Factors Distributors
12.3 Coagulation Factors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
